Evidence map›Paper›PMID 40321156›Full record

ArticleOpen life sciences2025

Small cell lung cancer with small intestinal metastasis: Case report and literature review.

Hai Zeng, Ziguo Liu, Min Zhu, Tian-E Zhang

Abstract readCase Reports
In one paragraph

Article in Open life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hai ZengDepartment of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, 434020, China.
Ziguo LiuThe First Affiliated Hospital of Yangtze University, Jingzhou, 434020, China.
Min ZhuThe First Affiliated Hospital of Yangtze University, Jingzhou, 434020, China.
Tian-E ZhangThe First Affiliated Hospital of Yangtze University, Jingzhou, 434020, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with small cell lung cancer (SCLC) typically exhibit a poor prognosis, often receiving diagnoses at an advanced stage. Despite recent advances in immunotherapy, the median survival remains approximately one year. Gastrointestinal metastases from lung cancer, based on clinical experience, are exceedingly rare and associated with dire prognoses. This article details the diagnosis and management of an unusual case of SCLC with gastrointestinal metastasis. The patient's survival was notably prolonged compared to typical SCLC outcomes, providing significant clinical insight.

Indexed as

gastrointestinal metastasisgastrointestinal perforationlung cancersmall cell lung cancersmall intestinal metastasis

Identifiers

PMID40321156
PMCPMC12048897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.